var data={"title":"Genetics and pathogenesis of nephronophthisis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Genetics and pathogenesis of nephronophthisis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/contributors\" class=\"contributor contributor_credentials\">Patrick Niaudet, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/contributors\" class=\"contributor contributor_credentials\">Tej K Mattoo, MD, DCH, FRCP</a></dd><dd><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/contributors\" class=\"contributor contributor_credentials\">Ronald D Perrone, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/contributors\" class=\"contributor contributor_credentials\">Melanie S Kim, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Mar 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 27, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disorder that typically progresses to end-stage renal disease (ESRD). It is caused by mutations in a large number of genes that encode proteins involved in the function of primary cilia, basal bodies, and centrosomes resulting in renal disease and extrarenal manifestations, including retinal degeneration, cerebellar ataxia, and liver fibrosis.</p><p>The genetics and pathogenesis of NPHP will be reviewed here. The clinical manifestations and management of NPHP are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2257782758\"><span class=\"h1\">OVERVIEW</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with NPHP have gene mutations that encode components of the ciliary apparatus [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Although mutations in <em>NPHP1</em> gene account for 20 percent of cases, at least 20 different genes have been associated with NPHP. All the genes encode proteins that are localized to the primary cilia, basal bodies, and centrosomes.</p><p>These gene defects result in the characteristic findings of NPHP:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Autosomal recessive inheritance</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Impaired urinary concentrating ability and sodium reabsorption</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bland urinalysis (absence of proteinuria, hematuria and cellular elements)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic tubulointerstitial nephritis and progression to end-stage renal disease (ESRD) generally before the age of 20 years</p><p/><p>Three clinical variants have been described based upon the median age of onset of ESRD [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Infantile &minus; one year of age</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Juvenile &minus; 13 years of age</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Adolescent &minus; 19 years of age</p><p/><p>These variants are associated with specific gene defects. In addition, abnormalities in extrarenal organs including hepatic fibrosis and retinal defects are often present and are usually also associated with a specific gene defect.</p><p>NPHP is included in the <span class=\"nowrap\">NPHP/medullary</span> cystic kidney disease complex (MCKD). In contrast to NPHP, MCKD is an autosomal dominant disorder that generally progresses to ESRD later in life during adulthood. A discussion on medullary cystic kidney disease is also found elsewhere. (See <a href=\"topic.htm?path=autosomal-dominant-tubulointerstitial-kidney-disease-medullary-cystic-kidney-disease\" class=\"medical medical_review\">&quot;Autosomal dominant tubulointerstitial kidney disease (medullary cystic kidney disease)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>NPHP is an uncommon condition equally distributed in males and females. The juvenile form, in which patients develop end-stage renal disease (ESRD) during childhood or adolescence, is the most common variant. Cases of juvenile NPHP have been reported worldwide [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/4\" class=\"abstract_t\">4</a>]. Estimated prevalence for this variant varies from 0.1 to 0.2 per 10,000 live births in reports from Finland and Canada [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3,4\" class=\"abstract_t\">3,4</a>].</p><p>It has been estimated that NPHP is responsible for approximately 2.4 percent of cases of ESRD in children in the United States [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/5\" class=\"abstract_t\">5</a>]. This may be an underestimate, since studies from Europe have revealed a higher frequency of 15 percent [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H174931069\"><span class=\"h1\">GENETICS</span></p><p class=\"headingAnchor\" id=\"H1508867298\"><span class=\"h2\">Overview</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with NPHP have gene mutations that encode components of the ciliary apparatus, which are expressed in primary cilia, basal bodies, or centrosomes (<a href=\"image.htm?imageKey=PEDS%2F90846\" class=\"graphic graphic_table graphicRef90846 \">table 1</a>) [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/1-3,7-22\" class=\"abstract_t\">1-3,7-22</a>].</p><p>Mutations of the <em>NPHP1</em> gene are the most common, being reported in approximately 20 percent of cases [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/2,3,23\" class=\"abstract_t\">2,3,23</a>]. Mutations in each of the other genes contribute less than 3 percent each [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3\" class=\"abstract_t\">3</a>]. The gene involved remains unknown in 30 percent of patients with NPHP [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/24\" class=\"abstract_t\">24</a>].</p><p class=\"headingAnchor\" id=\"H1128434434\"><span class=\"h3\">Clinical correlation and gene mutation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical findings vary with the involved gene [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/22\" class=\"abstract_t\">22</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis#H2\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Juvenile NPHP is associated with mutations in all the NPHP genes except <em>NPHP2</em>, including <em>NPHP1</em>, the most commonly affected gene.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in <em>NPHP2</em> and <em>NPHP3</em> result in infantile and adolescent NPHP, respectively [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/17,25\" class=\"abstract_t\">17,25</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in <em>NPHP5</em> are associated with retinitis pigmentosa (also referred to as tapetoretinal degeneration) and the Senior-Loken syndrome.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in <em>NPHP6</em> and <em>NPHP8</em> are associated with retinal degeneration and cerebellar vermis aplasia in the Joubert syndrome or Meckel-Gruber syndrome.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in <em>NPHP7</em> and <em>NPHP9</em> are rare causes of NPHP [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/20,21\" class=\"abstract_t\">20,21</a>].</p><p/><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">NPHP1 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The first gene, <em>NPHP1</em>, was identified via the use of positional cloning in consanguineous affected families and is located on chromosome 2q12.3 [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/8-10\" class=\"abstract_t\">8-10</a>]. <em>NPHP1</em> encodes for nephrocystin-1, which is located at the cell-cell junction (adherens junction) and the cell-matrix interface (focal adhesion) and is expressed primarily in the collecting duct [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3,26,27\" class=\"abstract_t\">3,26,27</a>]. It interacts with other NPHP proteins and participates in multiple intracellular signaling pathways that involve ciliary function. (See <a href=\"#H14\" class=\"local\">'Pathogenesis'</a> below.)</p><p>In large case series of patients diagnosed clinically with NPHP, homozygous deletions of the <em>NPHP1</em> gene is detected in approximately 25 percent of cases [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3\" class=\"abstract_t\">3</a>]. Heterozygous deletions may be associated with concomitant point mutation of the NPHP1 gene on the second allele.</p><p>Patients with <em>NPHP1</em> gene mutations generally present with juvenile NPHP. <em>NPHP1</em> gene deletions or mutations have also been described in association with moderate retinitis pigmentosa, Cogan syndrome with oculomotor apraxia, and a subset of individuals with Joubert syndrome [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/27-31\" class=\"abstract_t\">27-31</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis#H2\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">NPHP2 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>NPHP2</em>, located on chromosome 9q21-22, encodes for the protein inversin (also called nephrocystin-2) [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/16\" class=\"abstract_t\">16</a>]. Inversin is critical for the normal development of left-right patterning [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/16,32\" class=\"abstract_t\">16,32</a>] and is thought to be involved in the signaling mechanisms of planar cell polarity [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/33,34\" class=\"abstract_t\">33,34</a>]. Inversin is located in several different subcellular compartments including the primary cilia of the renal tubule where it interacts with both nephrocystin-1 and beta-tubulin, a major component of primary cilia [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3,16\" class=\"abstract_t\">3,16</a>]. Defects in this gene are responsible for the infantile form of NPHP with and without situs inversus [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/16\" class=\"abstract_t\">16</a>].</p><p>In patients with <em>NPHP2</em> gene mutations, histologic changes seen on renal biopsy combine features of NPHP and polycystic kidney disease: chronic tubulointerstitial nephritis with cortical microcysts. Partial deletion of this gene in a mouse model results in large renal cysts, situs inversus, and hepatobiliary duct malformations [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/35\" class=\"abstract_t\">35</a>].</p><p>Twenty-eight families with NPHP have been identified as having mutations of the <em>NPHP2</em> gene [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/22,36\" class=\"abstract_t\">22,36</a>]. The age of onset of end-stage renal disease (ESRD) was less than four years in all patients and less than 24 months in most of them [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/16\" class=\"abstract_t\">16</a>]. Hypertension is a constant finding. Other findings include situs inversus, heart valve or septal defects, liver disease, recurrent bronchitis, and optic nerve atrophy.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">NPHP3 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>NPHP3</em>, located on chromosome 3q22, encodes a protein with a tubulin-tyrosine ligase domain, which interacts with nephrocystin-I [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/17\" class=\"abstract_t\">17</a>]. In a mouse model, complete loss of the NPHP3 protein function may be associated with a very severe phenotype with embryonic lethality [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/37\" class=\"abstract_t\">37</a>]. In humans, there is a broad clinical spectrum of early embryonic patterning defects that include situs inversus, polydactyly, central nervous system malformations, structural heart defects, preauricular fistulas, and a wide range of congenital anomalies of the kidney and urinary tract [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/37\" class=\"abstract_t\">37</a>]. <em>NPHP3</em> gene mutations have been described in families with renal disease alone, as well as in families with renal disease associated with hepatic fibrosis, heart valve or septal defects, cone-shaped epiphysis, central nervous system anomalies, or retinitis pigmentosa [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/17,22,36\" class=\"abstract_t\">17,22,36</a>].</p><p>Although NPHP3 gene mutations are associated with the adolescent variant of NPHP (with a reported median age of 19 at the time of ESRD), the age range at ESRD varies from 4 to 37 years of age in patients with defects of this gene [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/38\" class=\"abstract_t\">38</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">NPHP4 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>NPHP4</em> gene, located on chromosome 1p36, encodes nephrocystin-4 (also referred to as nephroretinin), which localizes to primary cilia, basal bodies, and centrosomes, interacts with nephrocystin-1, and is involved with the same intracellular signaling pathway [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/15\" class=\"abstract_t\">15</a>]. <em>NPHP4</em> has been identified as a negative regulator of the Hippo pathway, which is involved in tumor suppression and the control of cell proliferation [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/39\" class=\"abstract_t\">39</a>]. In one study of 250 patients, 23 different <em>NPHP4</em> gene mutations were detected in 26 unrelated cases of juvenile NPHP [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/40\" class=\"abstract_t\">40</a>]. These cases included 13 of 190 patients with isolated NPHP, 8 of 50 with retinitis pigmentosa, and 2 of 10 with oculomotor apraxia. (See <a href=\"topic.htm?path=retinitis-pigmentosa-clinical-presentation-and-diagnosis\" class=\"medical medical_review\">&quot;Retinitis pigmentosa: Clinical presentation and diagnosis&quot;</a>.)</p><p>Nephrocystin-4 localizes to the connecting cilium of photoreceptor cells and interacts with a cone and rod receptor protein, RPGRIP1L (retinitis pigmentosa GTPase regulator interacting protein 1) [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/41\" class=\"abstract_t\">41</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">NPHP5 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>NPHP5</em> gene (also referred to as <em>IQCB1</em> gene) is located on chromosome 3q21 and encodes nephrocystin-5 [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/18\" class=\"abstract_t\">18</a>]. Nephrocystin-5 interacts with calmodulin and the retinitis pigmentosa GTPase regulator (RPGR) [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3\" class=\"abstract_t\">3</a>]. Since mutations in <em>RPGR</em> cause X-linked retinitis pigmentosa, the eye disorder resulting from defects in the <em>NPHP5</em> gene is likely due to a common functional pathway that involves the two proteins. Both nephrocystin-5 and retinitis pigmentosa GTPase regulator are expressed in the connecting cilia of photoreceptor and primary cilia of renal epithelial cells [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/18\" class=\"abstract_t\">18</a>]. (See <a href=\"topic.htm?path=retinitis-pigmentosa-clinical-presentation-and-diagnosis\" class=\"medical medical_review\">&quot;Retinitis pigmentosa: Clinical presentation and diagnosis&quot;</a> and <a href=\"#H14\" class=\"local\">'Pathogenesis'</a> below.)</p><p>All patients with mutations of the <em>NPHP5</em> gene have retinitis pigmentosa, and disruption of this gene appears to be the most frequent cause of Senior-Loken syndrome, in which retinitis pigmentosa accompanies NPHP. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis#H4\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;, section on 'Senior-Loken syndrome and retinitis pigmentosa'</a>.)</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">NPHP6 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>NPHP6</em> gene, also known as <em>CEP290</em>, is located on chromosome 12q21 and encodes a centrosomal protein that interacts with ATF4, a transcription factor involved in the control of the cell cycle [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/19,42\" class=\"abstract_t\">19,42</a>]. Mutations of the ATF4 gene are associated with cAMP-dependent renal cyst formation.</p><p>Several mutations in the <em>NPHP6</em> gene were reported in families with Joubert syndrome with and without renal involvement, Senior-Loken syndrome, and Meckel-Gruber syndrome [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/19,42,43\" class=\"abstract_t\">19,42,43</a>]. In addition, in two case series, NPHP6 gene mutations were one of the most common causes of Leber's congenital amaurosis (LCA), a recessive disorder of congenital severe vision impairment or blindness due to the abnormal development of photoreceptors without renal disease. <em>NPHP6</em> gene mutations accounted for 20 percent of LCA cases [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/44,45\" class=\"abstract_t\">44,45</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis#H2\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">NPHP7 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gene mutations in the <em>GLIS2</em> gene, located on chromosome 16p, is a rare cause of NPHP. The gene product is a Kruppel-like zinc finger protein, which, unlike other NPHP proteins, appears to be a transcriptional repressor without involvement in ciliary function. Mutations of this gene were reported in a single family with three affected children who developed ESRD by eight years of age [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/20\" class=\"abstract_t\">20</a>]. However, no mutations of this gene were identified in a cohort of 470 individuals with clinical features suggesting NPHP. In a mouse model, <em>NPHP7</em> gene mutation resulted in severe premature renal atrophy and fibrosis, suggesting that the gene product plays a role in the maintenance of renal tissue architecture by preventing apoptosis [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/20,46\" class=\"abstract_t\">20,46</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">NPHP8 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mutations in the <em>NPHP8</em> gene (also referred to as the <em>RPGRIP1L</em> gene) located on chromosome 16q, have been reported in a few families with Joubert syndrome and Meckel-Gruber syndrome [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/47,48\" class=\"abstract_t\">47,48</a>]. Mutations in the <em>NPHP8</em> gene may also cause retinal degeneration [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/49\" class=\"abstract_t\">49</a>]. Inactivation of the mouse orthologue recapitulated the cerebral, renal, and hepatic findings associated with these two disorders [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/47\" class=\"abstract_t\">47</a>]. The gene product colocalizes to the basal body and centrosomes with nephrocystin-4 and -6 [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/47,50\" class=\"abstract_t\">47,50</a>].</p><p><em>RPGRIP1L</em> participates in sonic hedgehog (Shh) signaling and plays a critical role in patterning of the developing neural tube and limb [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/51\" class=\"abstract_t\">51</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">NPHP9 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mutations in the <em>NPHP9</em> gene (also called the <em>NEK8</em> gene) are rare causes of NPHP.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In one cohort of 588 patients diagnosed with NPHP, three patients from different families had missense mutations in the Nek8 gene [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/21\" class=\"abstract_t\">21</a>]. One patient with homozygous mutation developed infantile NPHP, while in the other two patients, only one recessive mutation was identified. In one of them, an additional mutation of the <em>NPHP5</em> gene was present. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>NEK8</em> gene mutations were also observed in a third-degree consanguineous multiplex pedigree with three affected fetuses who presented with a multisystemic phenotype, which included enlarged cystic kidneys, liver, and pancreas and developmental heart disease [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/52\" class=\"abstract_t\">52</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A third case report described two brothers who presented in the newborn period with cardiac (hypertrophic cardiomyopathy), hepatic (bile duct hypoplasia), and renal anomalies (renal cystic dysplasia) [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/53\" class=\"abstract_t\">53</a>].</p><p/><p><em>NEK8</em> is a member of the NIMA (never in mitosis A)-related kinase (NEK) family, which is thought to coordinate the regulation of cilia and cell cycle progression. <em>NEK8</em> localizes to the primary cilia of renal epithelial cells.</p><p class=\"headingAnchor\" id=\"H174929653\"><span class=\"h2\">NPHP10 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mutations of the gene that encodes <em>SDCCAG8</em> (serologically defined colon cancer antigen 8, also known as the centrosomal colon cancer autoantigen protein [CCCAP]) have been identified in 10 families with retinitis pigmentosa and NPHP [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/54\" class=\"abstract_t\">54</a>]. <em>SDCCAG8</em> is localized at the centrioles of both renal epithelial and retinal photoreceptor cells. This finding supports the role of the cilia-centrosome-mitotic spindle complex for single-gene disorders that affect both the kidney and retina.</p><p class=\"headingAnchor\" id=\"H174929661\"><span class=\"h2\">NPHP11 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>NPHP11</em> gene at 8q22 is also known as the <em>MKS3</em> and <em>TMEM67</em> gene [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/22\" class=\"abstract_t\">22</a>]. It encodes meckelin, which is located at the base of primary cilia [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/22\" class=\"abstract_t\">22</a>]. Patients with this gene defect have clinical features of Joubert syndrome, an autosomal recessive neurologic disorder characterized by cerebellar vermis hypoplasia resulting in ataxia, polydactyly, hypotonia, developmental delay, neonatal respiratory dysregulation, and abnormal eye movements or Meckel-Gruber syndrome, an autosomal recessive lethal disorder characterized by central nervous system malformation (eg, occipital encephalocele), bilateral renal cystic dysplasia, cleft palate, polydactyly, and ductal proliferation in the portal area of the liver. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis#H6\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;, section on 'Joubert syndrome'</a> and <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis#H7\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;, section on 'Meckel-Gruber syndrome'</a>.)</p><p class=\"headingAnchor\" id=\"H798723663\"><span class=\"h2\">NPHP12 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>NPHP12</em> gene, also known as the <em>TTC21B</em>, <em>JBS11</em>, <em>SRTD4</em>, or <em>ATD4</em> gene, on chromosome 2 encodes IFT139, a subunit of the intraflagellar transport-A complex, which regulates the retrograde trafficking in the primary cilium [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/55\" class=\"abstract_t\">55</a>]. Mutations in this gene have been reported in patients with isolated NPHP, in patients with NPHP with hepatic fibrosis or bone anomalies, and in patients with Jeune asphyxiating thoracic dystrophy [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/56\" class=\"abstract_t\">56</a>]. A homozygous missense mutation, p.P209L, in this gene has been reported in seven families from North Africa or Portugal with proteinuria and focal and segmental glomerulosclerosis [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/57\" class=\"abstract_t\">57</a>]. Tubular basement membrane thickening, similar to that observed in patients with NPHP, was also noted. These patients had late-onset proteinuria and high blood pressure, and progressed to end-stage renal failure between 15 and 32 years. This observation shows that ciliary genes may also be involved in glomerular diseases.</p><p class=\"headingAnchor\" id=\"H798723669\"><span class=\"h2\">NPHP13 gene</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <em>NPHP13</em> gene, also known as <em>WRD19</em>, <em>SRDT5</em>, <em>ATD5</em>, or <em>CED4</em>, encodes IFT144, another subunit of the intraflagellar transport-A complex. Mutations in this gene have been identified in patients with isolated NPHP, NPHP and hepatic fibrosis, Senior-Loken syndrome, Caroli disease, Sensenbrenner syndrome, and Jeune syndrome [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/58-62\" class=\"abstract_t\">58-62</a>].</p><p class=\"headingAnchor\" id=\"H18852533\"><span class=\"h2\">Other genes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with defects in genes that affect components important for ciliary function may also present with NPHP. These include the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in the gene <em>SRDT9</em> encoding IFT140, another subunit of the intraflagellar transport-A complex, are responsible for Saldino-Mainzer syndrome and Jeune syndrome [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/63,64\" class=\"abstract_t\">63,64</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in genes encoding proteins of the intraflagellar transport-B complex involved in the anterograde transport in the primary cilium, <em>IFT27</em>, <em>IFT80</em>, <em>IFT172</em><span class=\"nowrap\">/<em>NPHP17</em>,</span> have been reported in patients with Jeune syndrome, Saldino-Mainzer syndrome, and Bardet-Biedl syndrome [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/24,65,66\" class=\"abstract_t\">24,65,66</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The <em>CEP83</em><span class=\"nowrap\">/<em>NPHP18</em></span> gene encodes one of the distal appendages (DAPs) of centrioles, which anchor cilia to the plasma membrane. Biallelic mutations of <em>CEP83</em> have been identified in seven families, with infantile NPHP associated with central nervous system abnormalities in half of the patients [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/67\" class=\"abstract_t\">67</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations of <em>ANKS6</em><span class=\"nowrap\">/<em>NPHP16</em>,</span> which encodes a protein that localizes to the proximal cilium and connects NEK8 (gene product of <em>NPHP9</em>) to inversin (gene product of <em>NPHP2</em>), have been reported in six families affected with NPHP, severe cardiovascular abnormalities, liver fibrosis, and situs inversus [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/68\" class=\"abstract_t\">68</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations of genes that encode for proteins within the DNA damage response pathway (ie, <em>MRE11</em>, <em>ZNF423</em><span class=\"nowrap\">/<em>NPHP14</em>,</span> and <em>CEP164</em><span class=\"nowrap\">/<em>NPHP15</em></span> genes) result in NPHP-related ciliopathies [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/69\" class=\"abstract_t\">69</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in the gene <em>TRAF3IP1</em>, encoding the IFT-B subunit, IFT54, were observed in eight individuals from five unrelated families [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/70\" class=\"abstract_t\">70</a>]. Patients presented with tubulointerstitial nephritis, leading to end-stage renal disease (ESRD) between 3 and 16 years and the Senior-Loken syndrome. Four patients had liver defects and six had skeletal anomalies.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in the <em>IFT81</em> gene, encoding an IFT-B core protein, have been reported as a very rare cause of ciliopathy dysfunction [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/71\" class=\"abstract_t\">71</a>]. One of the patients presented with NPHP and polydactyly.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations of the <em><span class=\"nowrap\">DCDC2/NPHP19</em></span> gene were detected in two patients from consanguineous families [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/72\" class=\"abstract_t\">72</a>]. One patient presented with hepatic fibrosis at 11 months and ESRD at 14 years from NPHP, while the second patient presented with early liver fibrosis, requiring liver transplantation at two years. <em>DCDC2</em> interacts with the mediator of Wnt signaling, thus demonstrating a central role of Wnt signaling in the pathogenesis of NPHP.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations in the gene encoding MAPKBP1, a scaffolding protein for the JNK signaling pathway were detected in eight individuals from five families presenting with late-onset NPHP with massive renal fibrosis [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/73\" class=\"abstract_t\">73</a>]. Interestingly, MAPKBP1 is not located in the primary cilium and may represent a group of new gene products resulting in NPHP, which are not involved in cilia-associated functions.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Defects in the genes <em>AHI1</em> and <em>CC2D2A</em> are also associated with NPHP and are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis#H73561245\" class=\"medical medical_review\">&quot;Clinical manifestations, diagnosis, and treatment of nephronophthisis&quot;, section on 'Associated syndromes'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H16175164\"><span class=\"h2\">Oligogenic inheritance</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Oligogenic inheritance has been reported in individuals with NPHP, in whom mutations in different NPHP genes occur. In a study of 94 families, patients from six families had two or more mutations in the <em>NPHP1</em>, <em>NPHP3</em>, and <em>NPHP4</em> genes [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/74\" class=\"abstract_t\">74</a>]. Oligogenic inheritance was also noted in some patients with Joubert syndrome who had mutations in both the <em>NPHP1</em> and <em>NPHP6</em> genes [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/31\" class=\"abstract_t\">31</a>].</p><p>The number of patients with oligogenic mutations is too low to draw any conclusions on <span class=\"nowrap\">genotype/phenotype</span> correlation, such as whether the presence of multiple mutations increases the severity of clinical findings.</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">PATHOGENESIS</span></p><p>Although it is uncertain exactly how the defects in the various NPHP genes lead to renal disease, the proposed common mechanism is ciliary dysfunction. This hypothesis is based upon the observation that most proteins associated with various forms of human renal cystic disease, including the nephrocystin proteins, localize to primary cilia, basal bodies, and centrosomes [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/18,19,75-77\" class=\"abstract_t\">18,19,75-77</a>].</p><p>Nephrocystins interact with one another and with other proteins (such as tensin, filamins, and tubulins) that are involved with cell-cell and cell-matrix signaling [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/15,16,77\" class=\"abstract_t\">15,16,77</a>]. It is thought that mutations in the NPHP genes alter cilia function via defects in intracellular signaling pathways, resulting in the inability of the ciliary mechanosensors to correctly sense luminal flow rates [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3,78\" class=\"abstract_t\">3,78</a>]. The inability of renal tubular cells to perceive luminal fluid flow due to dysfunctional ciliary function results in dysregulated tissue growth and subsequent development of renal cysts. (See <a href=\"topic.htm?path=genetics-of-autosomal-dominant-polycystic-kidney-disease-and-mechanisms-of-cyst-growth\" class=\"medical medical_review\">&quot;Genetics of autosomal dominant polycystic kidney disease and mechanisms of cyst growth&quot;</a>.)</p><p>Gene products of some of the NPHP genes are found in the cilia of other organs. Mutations of these genes result in the nonrenal manifestations of NPHP, such as retinitis pigmentosa, which occurs in 20 percent of all cases of NPHP. (See <a href=\"topic.htm?path=retinitis-pigmentosa-clinical-presentation-and-diagnosis\" class=\"medical medical_review\">&quot;Retinitis pigmentosa: Clinical presentation and diagnosis&quot;</a>.)</p><p>With the identification of causative genes for NPHP, a genotype-phenotype correlation is becoming more apparent. Additional insight into the pathogenesis and clinical manifestations of the different forms of NPHP is provided by studies in animal models that replicate the mutations of the different genes. The following observations illustrate some of the findings:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Histology of the kidneys of mice without functional <em>NPHP2</em> genes reveals tubular cysts and interstitial fibrosis, similar to the renal pathology seen in humans with <em>NPHP2</em> gene mutations [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/35,79,80\" class=\"abstract_t\">35,79,80</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mice with homozygous missense mutations in the murine homolog of <em>NPHP3</em> have similar renal pathology to that observed in patients with adolescent NPHP [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/81\" class=\"abstract_t\">81</a>]. In the mouse, <em>NPHP3</em> is expressed in those organs and tissue sites known to be affected in this disorder, including renal tubules, retina, liver, biliary tract, and neural tissues [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/17\" class=\"abstract_t\">17</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The renal, retinal, and cerebellar phenotype of Joubert syndrome can be reproduced by eliminating the function of the <em>NPHP6</em> gene in zebrafish [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/19\" class=\"abstract_t\">19</a>].</p><p/><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">PATHOLOGY</span></p><p class=\"headingAnchor\" id=\"H3886890392\"><span class=\"h2\">Juvenile and adolscent variant</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the juvenile and adolescent variants of NPHP, the kidneys are grossly normal or shrunken in appearance with small corticomedullary cysts up to 1.5 cm in size. Histologic changes include initial interstitial fibrosis and limited signs of inflammation, followed by severe tubular damage characterized by atrophic tubules with thickened and multilayered basement membranes [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/2\" class=\"abstract_t\">2</a>]. The glomeruli are often normal, but secondary segmental sclerosis is not uncommon in advanced disease. In the later stages of the disease, light microscopy demonstrates that groups of dilated or collapsed tubules alternate with the atrophied damaged tubules (<a href=\"image.htm?imageKey=PEDS%2F66242\" class=\"graphic graphic_picture graphicRef66242 \">picture 1</a>). This is often accompanied by collapsed glomeruli with severe periglomerular fibrosis. </p><p>On electron microscopy, homogeneous or multilayered thickening of tubular basement membranes is prominent along with duplication [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/82\" class=\"abstract_t\">82</a>]. Disintegration of the basement membrane also can occur.</p><p class=\"headingAnchor\" id=\"H1360397733\"><span class=\"h2\">Infantile variant</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the infantile variant, the kidneys are moderately enlarged and histologic changes include a diffuse chronic tubulo-interstitial nephritis and microcystic dilatations of proximal tubules and Bowman's spaces [<a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/83\" class=\"abstract_t\">83</a>]. As a result, the kidneys are larger than normal due to the presence of cysts similar to those seen in patients with autosomal dominant polycystic kidney disease who present in early childhood. (See <a href=\"topic.htm?path=autosomal-dominant-polycystic-kidney-disease-in-children\" class=\"medical medical_review\">&quot;Autosomal dominant polycystic kidney disease in children&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nephronophthisis (NPHP) is an autosomal recessive disorder that is characterized by a reduced urinary concentrating ability with a bland urinary sediment, chronic tubulointerstitial nephritis, and progression to end-stage renal disease (ESRD) at an early age (generally before the age of 20 years).</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mutations of several genes whose protein products are expressed in primary cilia, basal bodies, or centrosomes, have been identified in patients with NPHP. The gene products are thought to have roles in cell-cell and cell-matrix signaling, which involve sensing luminal flow rates within the renal tubules via ciliary mechanosensors. Genetic defects lead to dysregulation of tissue growth and cyst formation as a consequence of the abnormal renal cells&rsquo; attempt to compensate for a perceived lack of fluid flow. (See <a href=\"#H174931069\" class=\"local\">'Genetics'</a> above and <a href=\"#H14\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Three clinical variants have been described based upon the median age of onset of ESRD. These variants are associated with specific gene defects. (See <a href=\"#H174931069\" class=\"local\">'Genetics'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The juvenile form (median onset of ESRD is 13 years of age) is the most common variant and is associated with mutations in all the NPHP genes except <em>NPHP2</em>. In particular, patients with mutations of the <em>NPHP1</em> gene, the most commonly affected gene, present with juvenile NPHP.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The infantile (median onset of ESRD by one year of age) form is associated with mutations in the <em>NPHP2</em> gene and the adolescent form with mutations of the <em>NPHP3</em> gene.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Characteristic pathologic features include severe tubular damage of atrophic tubules with thickened basement membranes alternating with groups of dilated or collapsed tubules demonstrated on light microscopy with normal appearing glomeruli (<a href=\"image.htm?imageKey=PEDS%2F66242\" class=\"graphic graphic_picture graphicRef66242 \">picture 1</a>). (See <a href=\"#H15\" class=\"local\">'Pathology'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/1\" class=\"nounderline abstract_t\">Srivastava S, Sayer JA. Nephronophthisis. J Pediatr Genet 2014; 3:103.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/2\" class=\"nounderline abstract_t\">Srivastava S, Molinari E, Raman S, Sayer JA. Many Genes-One Disease? Genetics of Nephronophthisis (NPHP) and NPHP-Associated Disorders. Front Pediatr 2017; 5:287.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/3\" class=\"nounderline abstract_t\">Hildebrandt F, Attanasio M, Otto E. Nephronophthisis: disease mechanisms of a ciliopathy. J Am Soc Nephrol 2009; 20:23.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/4\" class=\"nounderline abstract_t\">Levy M, Feingold J. Estimating prevalence in single-gene kidney diseases progressing to renal failure. Kidney Int 2000; 58:925.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/5\" class=\"nounderline abstract_t\">Alexander SR, Sullivan EK, Harmon WE, et al. Maintenance dialysis in North American children and adolescents: a preliminary report. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Kidney Int Suppl 1993; 43:S104.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/6\" class=\"nounderline abstract_t\">Konrad M, Saunier S, Heidet L, et al. Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis. Hum Mol Genet 1996; 5:367.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/7\" class=\"nounderline abstract_t\">Johnson CA, Gissen P, Sergi C. Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes. J Med Genet 2003; 40:311.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/8\" class=\"nounderline abstract_t\">Antignac C, Arduy CH, Beckmann JS, et al. A gene for familial juvenile nephronophthisis (recessive medullary cystic kidney disease) maps to chromosome 2p. Nat Genet 1993; 3:342.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/9\" class=\"nounderline abstract_t\">Hildebrandt F, Otto E, Rensing C, et al. A novel gene encoding an SH3 domain protein is mutated in nephronophthisis type 1. Nat Genet 1997; 17:149.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/10\" class=\"nounderline abstract_t\">Saunier S, Calado J, Heilig R, et al. A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis. Hum Mol Genet 1997; 6:2317.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/11\" class=\"nounderline abstract_t\">Hildebrandt F, Strahm B, Nothwang HG, et al. Molecular genetic identification of families with juvenile nephronophthisis type 1: rate of progression to renal failure. APN Study Group. Arbeitsgemeinschaft f&uuml;r P&auml;diatrische Nephrologie. Kidney Int 1997; 51:261.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/12\" class=\"nounderline abstract_t\">Haider NB, Carmi R, Shalev H, et al. A Bedouin kindred with infantile nephronophthisis demonstrates linkage to chromosome 9 by homozygosity mapping. Am J Hum Genet 1998; 63:1404.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/13\" class=\"nounderline abstract_t\">Omran H, H&auml;ffner K, Vollmer M, et al. Exclusion of the candidate genes ACE and Bcl-2 for six families with nephronophthisis not linked to the NPH1 locus. Nephrol Dial Transplant 1999; 14:2328.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/14\" class=\"nounderline abstract_t\">Hildebrandt F, Rensing C, Betz R, et al. Establishing an algorithm for molecular genetic diagnostics in 127 families with juvenile nephronophthisis. Kidney Int 2001; 59:434.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/15\" class=\"nounderline abstract_t\">Mollet G, Salomon R, Gribouval O, et al. The gene mutated in juvenile nephronophthisis type 4 encodes a novel protein that interacts with nephrocystin. Nat Genet 2002; 32:300.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/16\" class=\"nounderline abstract_t\">Otto EA, Schermer B, Obara T, et al. Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat Genet 2003; 34:413.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/17\" class=\"nounderline abstract_t\">Olbrich H, Fliegauf M, Hoefele J, et al. Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat Genet 2003; 34:455.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/18\" class=\"nounderline abstract_t\">Otto EA, Loeys B, Khanna H, et al. Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin. Nat Genet 2005; 37:282.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/19\" class=\"nounderline abstract_t\">Sayer JA, Otto EA, O'Toole JF, et al. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat Genet 2006; 38:674.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/20\" class=\"nounderline abstract_t\">Attanasio M, Uhlenhaut NH, Sousa VH, et al. Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat Genet 2007; 39:1018.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/21\" class=\"nounderline abstract_t\">Otto EA, Trapp ML, Schultheiss UT, et al. NEK8 mutations affect ciliary and centrosomal localization and may cause nephronophthisis. J Am Soc Nephrol 2008; 19:587.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/22\" class=\"nounderline abstract_t\">Chaki M, Hoefele J, Allen SJ, et al. Genotype-phenotype correlation in 440 patients with NPHP-related ciliopathies. Kidney Int 2011; 80:1239.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/23\" class=\"nounderline abstract_t\">Caridi G, Dagnino M, Gusmano R, et al. Clinical and molecular heterogeneity of juvenile nephronophthisis in Italy: insights from molecular screening. Am J Kidney Dis 2000; 35:44.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/24\" class=\"nounderline abstract_t\">Halbritter J, Bizet AA, Schmidts M, et al. Defects in the IFT-B component IFT172 cause Jeune and Mainzer-Saldino syndromes in humans. Am J Hum Genet 2013; 93:915.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/25\" class=\"nounderline abstract_t\">Watnick T, Germino G. From cilia to cyst. Nat Genet 2003; 34:355.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/26\" class=\"nounderline abstract_t\">Donaldson JC, Dise RS, Ritchie MD, Hanks SK. Nephrocystin-conserved domains involved in targeting to epithelial cell-cell junctions, interaction with filamins, and establishing cell polarity. J Biol Chem 2002; 277:29028.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/27\" class=\"nounderline abstract_t\">Caridi G, Dagnino M, Rossi A, et al. Nephronophthisis type 1 deletion syndrome with neurological symptoms: prevalence and significance of the association. Kidney Int 2006; 70:1342.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/28\" class=\"nounderline abstract_t\">Caridi G, Murer L, Bellantuono R, et al. Renal-retinal syndromes: association of retinal anomalies and recessive nephronophthisis in patients with homozygous deletion of the NPH1 locus. Am J Kidney Dis 1998; 32:1059.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/29\" class=\"nounderline abstract_t\">Betz R, Rensing C, Otto E, et al. Children with ocular motor apraxia type Cogan carry deletions in the gene (NPHP1) for juvenile nephronophthisis. J Pediatr 2000; 136:828.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/30\" class=\"nounderline abstract_t\">Parisi MA, Bennett CL, Eckert ML, et al. The NPHP1 gene deletion associated with juvenile nephronophthisis is present in a subset of individuals with Joubert syndrome. Am J Hum Genet 2004; 75:82.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/31\" class=\"nounderline abstract_t\">Tory K, Lacoste T, Burglen L, et al. High NPHP1 and NPHP6 mutation rate in patients with Joubert syndrome and nephronophthisis: potential epistatic effect of NPHP6 and AHI1 mutations in patients with NPHP1 mutations. J Am Soc Nephrol 2007; 18:1566.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/32\" class=\"nounderline abstract_t\">Eley L, Turnpenny L, Yates LM, et al. A perspective on inversin. Cell Biol Int 2004; 28:119.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/33\" class=\"nounderline abstract_t\">Simons M, Gloy J, Ganner A, et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 2005; 37:537.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/34\" class=\"nounderline abstract_t\">Simons M, Walz G. Polycystic kidney disease: cell division without a c(l)ue? Kidney Int 2006; 70:854.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/35\" class=\"nounderline abstract_t\">Morgan D, Turnpenny L, Goodship J, et al. Inversin, a novel gene in the vertebrate left-right axis pathway, is partially deleted in the inv mouse. Nat Genet 1998; 20:149.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/36\" class=\"nounderline abstract_t\">Tory K, Rousset-Rouvi&egrave;re C, Gubler MC, et al. Mutations of NPHP2 and NPHP3 in infantile nephronophthisis. Kidney Int 2009; 75:839.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/37\" class=\"nounderline abstract_t\">Bergmann C, Fliegauf M, Br&uuml;chle NO, et al. Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia. Am J Hum Genet 2008; 82:959.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/38\" class=\"nounderline abstract_t\">Omran H, Fernandez C, Jung M, et al. Identification of a new gene locus for adolescent nephronophthisis, on chromosome 3q22 in a large Venezuelan pedigree. Am J Hum Genet 2000; 66:118.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/39\" class=\"nounderline abstract_t\">Habbig S, Bartram MP, M&uuml;ller RU, et al. NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway. J Cell Biol 2011; 193:633.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/40\" class=\"nounderline abstract_t\">Hoefele J, Sudbrak R, Reinhardt R, et al. Mutational analysis of the NPHP4 gene in 250 patients with nephronophthisis. Hum Mutat 2005; 25:411.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/41\" class=\"nounderline abstract_t\">Roepman R, Letteboer SJ, Arts HH, et al. Interaction of nephrocystin-4 and RPGRIP1 is disrupted by nephronophthisis or Leber congenital amaurosis-associated mutations. Proc Natl Acad Sci U S A 2005; 102:18520.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/42\" class=\"nounderline abstract_t\">Valente EM, Silhavy JL, Brancati F, et al. Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome. Nat Genet 2006; 38:623.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/43\" class=\"nounderline abstract_t\">Helou J, Otto EA, Attanasio M, et al. Mutation analysis of NPHP6/CEP290 in patients with Joubert syndrome and Senior-L&oslash;ken syndrome. J Med Genet 2007; 44:657.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/44\" class=\"nounderline abstract_t\">Perrault I, Delphin N, Hanein S, et al. Spectrum of NPHP6/CEP290 mutations in Leber congenital amaurosis and delineation of the associated phenotype. Hum Mutat 2007; 28:416.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/45\" class=\"nounderline abstract_t\">den Hollander AI, Koenekoop RK, Yzer S, et al. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis. Am J Hum Genet 2006; 79:556.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/46\" class=\"nounderline abstract_t\">Kim YS, Kang HS, Herbert R, et al. Kruppel-like zinc finger protein Glis2 is essential for the maintenance of normal renal functions. Mol Cell Biol 2008; 28:2358.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/47\" class=\"nounderline abstract_t\">Delous M, Baala L, Salomon R, et al. The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome. Nat Genet 2007; 39:875.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/48\" class=\"nounderline abstract_t\">Wolf MT, Saunier S, O'Toole JF, et al. Mutational analysis of the RPGRIP1L gene in patients with Joubert syndrome and nephronophthisis. Kidney Int 2007; 72:1520.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/49\" class=\"nounderline abstract_t\">Khanna H, Davis EE, Murga-Zamalloa CA, et al. A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies. Nat Genet 2009; 41:739.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/50\" class=\"nounderline abstract_t\">Arts HH, Doherty D, van Beersum SE, et al. Mutations in the gene encoding the basal body protein RPGRIP1L, a nephrocystin-4 interactor, cause Joubert syndrome. Nat Genet 2007; 39:882.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/51\" class=\"nounderline abstract_t\">Vierkotten J, Dildrop R, Peters T, et al. Ftm is a novel basal body protein of cilia involved in Shh signalling. Development 2007; 134:2569.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/52\" class=\"nounderline abstract_t\">Frank V, Habbig S, Bartram MP, et al. Mutations in NEK8 link multiple organ dysplasia with altered Hippo signalling and increased c-MYC expression. Hum Mol Genet 2013; 22:2177.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/53\" class=\"nounderline abstract_t\">Rajagopalan R, Grochowski CM, Gilbert MA, et al. Compound heterozygous mutations in NEK8 in siblings with end-stage renal disease with hepatic and cardiac anomalies. Am J Med Genet A 2016; 170:750.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/54\" class=\"nounderline abstract_t\">Otto EA, Hurd TW, Airik R, et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nat Genet 2010; 42:840.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/55\" class=\"nounderline abstract_t\">Taschner M, Bhogaraju S, Lorentzen E. Architecture and function of IFT complex proteins in ciliogenesis. Differentiation 2012; 83:S12.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/56\" class=\"nounderline abstract_t\">Davis EE, Zhang Q, Liu Q, et al. TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum. Nat Genet 2011; 43:189.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/57\" class=\"nounderline abstract_t\">Huynh Cong E, Bizet AA, Boyer O, et al. A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS. J Am Soc Nephrol 2014; 25:2435.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/58\" class=\"nounderline abstract_t\">Bredrup C, Saunier S, Oud MM, et al. Ciliopathies with skeletal anomalies and renal insufficiency due to mutations in the IFT-A gene WDR19. Am J Hum Genet 2011; 89:634.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/59\" class=\"nounderline abstract_t\">Coussa RG, Otto EA, Gee HY, et al. WDR19: an ancient, retrograde, intraflagellar ciliary protein is mutated in autosomal recessive retinitis pigmentosa and in Senior-Loken syndrome. Clin Genet 2013; 84:150.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/60\" class=\"nounderline abstract_t\">Halbritter J, Porath JD, Diaz KA, et al. Identification of 99 novel mutations in a worldwide cohort of 1,056 patients with a nephronophthisis-related ciliopathy. Hum Genet 2013; 132:865.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/61\" class=\"nounderline abstract_t\">Fehrenbach H, Decker C, Eisenberger T, et al. Mutations in WDR19 encoding the intraflagellar transport component IFT144 cause a broad spectrum of ciliopathies. Pediatr Nephrol 2014; 29:1451.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/62\" class=\"nounderline abstract_t\">Lee JM, Ahn YH, Kang HG, et al. Nephronophthisis 13: implications of its association with Caroli disease and altered intracellular localization of WDR19 in the kidney. Pediatr Nephrol 2015; 30:1451.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/63\" class=\"nounderline abstract_t\">Perrault I, Saunier S, Hanein S, et al. Mainzer-Saldino syndrome is a ciliopathy caused by IFT140 mutations. Am J Hum Genet 2012; 90:864.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/64\" class=\"nounderline abstract_t\">Schmidts M, Frank V, Eisenberger T, et al. Combined NGS approaches identify mutations in the intraflagellar transport gene IFT140 in skeletal ciliopathies with early progressive kidney Disease. Hum Mutat 2013; 34:714.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/65\" class=\"nounderline abstract_t\">Aldahmesh MA, Li Y, Alhashem A, et al. IFT27, encoding a small GTPase component of IFT particles, is mutated in a consanguineous family with Bardet-Biedl syndrome. Hum Mol Genet 2014; 23:3307.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/66\" class=\"nounderline abstract_t\">Beales PL, Bland E, Tobin JL, et al. IFT80, which encodes a conserved intraflagellar transport protein, is mutated in Jeune asphyxiating thoracic dystrophy. Nat Genet 2007; 39:727.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/67\" class=\"nounderline abstract_t\">Failler M, Gee HY, Krug P, et al. Mutations of CEP83 cause infantile nephronophthisis and intellectual disability. Am J Hum Genet 2014; 94:905.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/68\" class=\"nounderline abstract_t\">Hoff S, Halbritter J, Epting D, et al. ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet 2013; 45:951.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/69\" class=\"nounderline abstract_t\">Chaki M, Airik R, Ghosh AK, et al. Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell 2012; 150:533.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/70\" class=\"nounderline abstract_t\">Bizet AA, Becker-Heck A, Ryan R, et al. Mutations in TRAF3IP1/IFT54 reveal a new role for IFT proteins in microtubule stabilization. Nat Commun 2015; 6:8666.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/71\" class=\"nounderline abstract_t\">Perrault I, Halbritter J, Porath JD, et al. IFT81, encoding an IFT-B core protein, as a very rare cause of a ciliopathy phenotype. J Med Genet 2015; 52:657.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/72\" class=\"nounderline abstract_t\">Schueler M, Braun DA, Chandrasekar G, et al. DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling. Am J Hum Genet 2015; 96:81.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/73\" class=\"nounderline abstract_t\">Macia MS, Halbritter J, Delous M, et al. Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis. Am J Hum Genet 2017; 100:372.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/74\" class=\"nounderline abstract_t\">Hoefele J, Wolf MT, O'Toole JF, et al. Evidence of oligogenic inheritance in nephronophthisis. J Am Soc Nephrol 2007; 18:2789.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/75\" class=\"nounderline abstract_t\">Fliegauf M, Horvath J, von Schnakenburg C, et al. Nephrocystin specifically localizes to the transition zone of renal and respiratory cilia and photoreceptor connecting cilia. J Am Soc Nephrol 2006; 17:2424.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/76\" class=\"nounderline abstract_t\">N&uuml;rnberger J, Kribben A, Opazo Saez A, et al. The Invs gene encodes a microtubule-associated protein. J Am Soc Nephrol 2004; 15:1700.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/77\" class=\"nounderline abstract_t\">Mollet G, Silbermann F, Delous M, et al. Characterization of the nephrocystin/nephrocystin-4 complex and subcellular localization of nephrocystin-4 to primary cilia and centrosomes. Hum Mol Genet 2005; 14:645.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/78\" class=\"nounderline abstract_t\">Fliegauf M, Benzing T, Omran H. When cilia go bad: cilia defects and ciliopathies. Nat Rev Mol Cell Biol 2007; 8:880.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/79\" class=\"nounderline abstract_t\">Mochizuki T, Saijoh Y, Tsuchiya K, et al. Cloning of inv, a gene that controls left/right asymmetry and kidney development. Nature 1998; 395:177.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/80\" class=\"nounderline abstract_t\">Phillips CL, Miller KJ, Filson AJ, et al. Renal cysts of inv/inv mice resemble early infantile nephronophthisis. J Am Soc Nephrol 2004; 15:1744.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/81\" class=\"nounderline abstract_t\">Omran H, Sasmaz G, H&auml;ffner K, et al. Identification of a gene locus for Senior-L&oslash;ken syndrome in the region of the nephronophthisis type 3 gene. J Am Soc Nephrol 2002; 13:75.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/82\" class=\"nounderline abstract_t\">Zollinger HU, Mihatsch MJ, Edefonti A, et al. Nephronophthisis (medullary cystic disease of the kidney). A study using electron microscopy, immunofluorescence, and a review of the morphological findings. Helv Paediatr Acta 1980; 35:509.</a></li><li><a href=\"https://www.uptodate.com/contents/genetics-and-pathogenesis-of-nephronophthisis/abstract/83\" class=\"nounderline abstract_t\">Gagnadoux MF, Bacri JL, Broyer M, Habib R. Infantile chronic tubulo-interstitial nephritis with cortical microcysts: variant of nephronophthisis or new disease entity? Pediatr Nephrol 1989; 3:50.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6136 Version 17.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H16\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2257782758\" id=\"outline-link-H2257782758\">OVERVIEW</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H174931069\" id=\"outline-link-H174931069\">GENETICS</a><ul><li><a href=\"#H1508867298\" id=\"outline-link-H1508867298\">Overview</a><ul><li><a href=\"#H1128434434\" id=\"outline-link-H1128434434\">- Clinical correlation and gene mutation</a></li></ul></li><li><a href=\"#H4\" id=\"outline-link-H4\">NPHP1 gene</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">NPHP2 gene</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">NPHP3 gene</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">NPHP4 gene</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">NPHP5 gene</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">NPHP6 gene</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">NPHP7 gene</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">NPHP8 gene</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">NPHP9 gene</a></li><li><a href=\"#H174929653\" id=\"outline-link-H174929653\">NPHP10 gene</a></li><li><a href=\"#H174929661\" id=\"outline-link-H174929661\">NPHP11 gene</a></li><li><a href=\"#H798723663\" id=\"outline-link-H798723663\">NPHP12 gene</a></li><li><a href=\"#H798723669\" id=\"outline-link-H798723669\">NPHP13 gene</a></li><li><a href=\"#H18852533\" id=\"outline-link-H18852533\">Other genes</a></li><li><a href=\"#H16175164\" id=\"outline-link-H16175164\">Oligogenic inheritance</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">PATHOGENESIS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">PATHOLOGY</a><ul><li><a href=\"#H3886890392\" id=\"outline-link-H3886890392\">Juvenile and adolscent variant</a></li><li><a href=\"#H1360397733\" id=\"outline-link-H1360397733\">Infantile variant</a></li></ul></li><li><a href=\"#H16\" id=\"outline-link-H16\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PEDS/6136|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/66242\" class=\"graphic graphic_picture\">- Histology of nephrophthisis</a></li></ul></li><li><div id=\"PEDS/6136|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PEDS/90846\" class=\"graphic graphic_table\">- Gene mutations in nephronophthisis</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=autosomal-dominant-polycystic-kidney-disease-in-children\" class=\"medical medical_review\">Autosomal dominant polycystic kidney disease in children</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autosomal-dominant-tubulointerstitial-kidney-disease-medullary-cystic-kidney-disease\" class=\"medical medical_review\">Autosomal dominant tubulointerstitial kidney disease (medullary cystic kidney disease)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-nephronophthisis\" class=\"medical medical_review\">Clinical manifestations, diagnosis, and treatment of nephronophthisis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=genetics-of-autosomal-dominant-polycystic-kidney-disease-and-mechanisms-of-cyst-growth\" class=\"medical medical_review\">Genetics of autosomal dominant polycystic kidney disease and mechanisms of cyst growth</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=retinitis-pigmentosa-clinical-presentation-and-diagnosis\" class=\"medical medical_review\">Retinitis pigmentosa: Clinical presentation and diagnosis</a></li></ul></div></div>","javascript":null}